Martin E Dowty
6PUBLICATIONS
23CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 18, 2024
Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry Perspective.Micaela B Reddy, Tamara D Cabalu, Loeckie de Zwart
|Aug 07, 2024
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans.Jonathan N Bauman, Angela C Doran, Gabrielle M Gualtieri
|May 27, 2024
Integrating Clinical Variability into PBPK Models for Virtual Bioequivalence of Single and Multiple Doses of Tofacitinib Modified-Release Dosage Form.Vivek Purohit, Kazuko Sagawa, Hao-Jui Hsu
|May 08, 2024
The Metabolism and Disposition of Brepocitinib in Humans and Characterization of the Formation Mechanism of an Aminopyridine Metabolite.Martin E Dowty, Ruolun Qiu, Alyssa Dantonio
|Jun 14, 2022
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Abrocitinib, a Selective Janus Kinase Inhibitor, in Humans.Jonathan N Bauman, Angela C Doran, Amanda King-Ahmad
|Dec 14, 2019
Janus kinase inhibitors for the treatment of rheumatoid arthritis demonstrate similar profiles of in vitro cytokine receptor inhibition.Martin E Dowty, Tsung H Lin, Michael I Jesson
Pageof 1
Frequent Collaborators
1 joint publications
Mark Niosi
1 joint publications
Vivek Purohit
1 joint publications
Kazuko Sagawa
1 joint publications
Hao-Jui Hsu
1 joint publications
Susanna Tse
1 joint publications
Arnab Mukherjee
1 joint publications
Cheng Chang
1 joint publications
Matthew A Cerny
1 joint publications
Micaela B Reddy
1 joint publications
Loeckie de Zwart
